Πέμπτη 26 Σεπτεμβρίου 2019


6-minute walking test: a useful tool in the management of heart failure patients? by Sophia Giannitsi et al.
The place of ARBs in heart failure therapy: is aldosterone suppression the key? by Uma Markan et al.
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome by Liping Zhang et al.
Therapeutic Advances in Cardiovascular Disease is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of cardiovascular disease. 

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου